LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (Nasdaq: CRTX) today hosted its 2007 Analyst Day at the Four Seasons Hotel in New York. During the event, the Company:
1. announced its September 27, 2007 U.S. launch date for ZYFLO CRTM (zileuton) extended-release tablets;
2. updated analysts and investors on its ZYFLO CR launch strategy and co-promotion partnership with Dey, L.P. (DEY);
3. reviewed the Company’s three clinical development programs and its two novel drug candidates in preclinical development programs; and
